José Seijas‐Amigo

Also affiliated with Instituto de Investigación Sanitaria de Santiago

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial”.

Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial

CHEST Journal(2023)10.1016/j.chest.2023.11.019

N/A

0.216DataRank · unranked

3 citations

Kinsley Hubel, Joshua Froess, Stephen R. Wisniewski, Vidya Venugopal, Yu‐Hsuan Lai +23 more

The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats

Biomedicine & Pharmacotherapy(2023)10.1016/j.biopha.2023.114535

N/A

0DataRank · unranked

28 citations

Sandra Moraña‐Fernández, Manuel Otero-Santiago, Laura Anido‐Varela, Manuel Campos‐Toimil, Javier García‐Seara +13 more